ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 97

$1.37M Total Retail Price of All Prescriptions

Rank: 1 out of 97

265 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

67% of this provider’s 265 patients filled at least one prescription for a schedule two drug, compared to an average of 40%.

Schedule Three
Controlled Substances

49% of this provider’s 265 patients filled at least one prescription for a schedule three drug, compared to an average of 36%.

Risky Drugs to Seniors

4% of this provider’s 1,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$213 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 945 264 S3 1 1
OXYCONTIN 468 55 S2 2 7
MORPHINE SULFATE ER 392 84 S2 3 3
OXYCODONE HCL 376 72 S2 4 4
OPANA ER 331 48 S2 5 25
FENTANYL 308 91 S2 6 5
GABAPENTIN 285 98 7 2
CARISOPRODOL 241 47 R 8 6
LYRICA 224 57 9 13
OXYCODONE HCL-ACETAMINOPHEN 219 23 S2 10 8
HYDROMORPHONE HCL 203 43 S2 11 11
TRAMADOL HCL 147 49 12 10
LIDODERM 144 79 13 16
TRAZODONE HCL 128 27 14 31
CYMBALTA 122 51 15 19
ENDOCET 104 21 S2 16 35
MORPHINE SULFATE 100 55 S2 17 14
NUCYNTA 98 0 S2 18 52
CYCLOBENZAPRINE HCL 93 21 R 19 20
VOLTAREN 84 38 20 22
ACETAMINOPHEN-CODEINE 76 27 S3 21 26
LUNESTA 72 0 22 83
ZOLPIDEM TARTRATE 61 18 23 12
METHADONE HCL 60 24 S2 24 9
OXYCODONE-ACETAMINOPHEN 59 48 S2 25 21
BACLOFEN 59 33 25 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.